DPIM
Duff & Phelps Investment Management Portfolio holdings
AUM
$8.51B
This Quarter Return
+2.86%
1 Year Return
+17.19%
3 Year Return
+25.16%
5 Year Return
+63.79%
10 Year Return
+120.91%
AUM
$5.96B
AUM Growth
+$5.96B
(-3.8%)
Cap. Flow
-$302M
Cap. Flow
% of AUM
-5.07%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
240
New
8
Increased
34
Reduced
167
Closed
4
Top Buys
| 1 |
MPLX
MPLX
|
$46.7M |
| 2 |
Black Hills Corp
BKH
|
$46.4M |
| 3 |
PGRE
Paramount Group
PGRE
|
$26.6M |
| 4 |
WEC Energy
WEC
|
$22.9M |
| 5 |
Digital Realty Trust
DLR
|
$14.2M |
Top Sells
| 1 |
Duke Energy
DUK
|
$109M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
$86.3M |
| 3 |
MWE
MARKWEST ENERGY PARTNERS, LP
MWE
|
$54.6M |
| 4 |
Extra Space Storage
EXR
|
$37.1M |
| 5 |
Prologis
PLD
|
$24.6M |
Sector Composition
| 1 | Real Estate | 35.93% |
| 2 | Utilities | 31.51% |
| 3 | Energy | 16.88% |
| 4 | Communication Services | 5.35% |
| 5 | Industrials | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Visa
V
$683B
| $2.5M | 0.04% | 32,190 -1,540 | -5% | -$119K |
|
|
TOO
152
DELISTED
Teekay Offshore Partners L.P.
TOO
| $2.49M | 0.04% | 384,919 | – | – |
|
153
Gilead Sciences
GILD
$140B
| $2.45M | 0.04% | 24,245 -1,120 | -4% | -$113K |
|
154
Merck
MRK
$210B
| $2.45M | 0.04% | 46,423 -2,260 | -5% | -$119K |
|
155
Wells Fargo
WFC
$263B
| $2.44M | 0.04% | 44,894 | – | – |
|
156
PepsiCo
PEP
$204B
| $2.42M | 0.04% | 24,175 -1,160 | -5% | -$116K |
|
157
Allete
ALE
$3.72B
| $2.4M | 0.04% | 47,190 -6,460 | -12% | -$328K |
|
158
Comcast
CMCSA
$125B
| $2.38M | 0.04% | 42,220 -680 | -2% | -$38.4K |
|
159
Cisco
CSCO
$274B
| $2.27M | 0.04% | 83,700 -4,120 | -5% | -$112K |
|
160
Philip Morris
PM
$260B
| $2.25M | 0.04% | 25,545 -1,220 | -5% | -$107K |
|
161
IBM
IBM
$227B
| $2.06M | 0.03% | 14,935 -710 | -5% | -$97.7K |
|
162
Amgen
AMGN
$155B
| $2.02M | 0.03% | 12,425 -640 | -5% | -$104K |
|
|
AGN
163
DELISTED
Allergan plc
AGN
| $2M | 0.03% | 6,405 -330 | -5% | -$103K |
|
164
Oracle
ORCL
$635B
| $1.96M | 0.03% | 53,590 -2,570 | -5% | -$93.9K |
|
165
Bristol-Myers Squibb
BMY
$96B
| $1.89M | 0.03% | 27,470 -1,330 | -5% | -$91.5K |
|
166
Altria Group
MO
$113B
| $1.88M | 0.03% | 32,315 -1,570 | -5% | -$91.4K |
|
167
UnitedHealth
UNH
$281B
| $1.85M | 0.03% | 15,715 -770 | -5% | -$90.6K |
|
168
McDonald's
MCD
$224B
| $1.83M | 0.03% | 15,510 -740 | -5% | -$87.4K |
|
169
Medtronic
MDT
$119B
| $1.8M | 0.03% | 23,330 -1,170 | -5% | -$90K |
|
170
CVS Health
CVS
$92.8B
| $1.79M | 0.03% | 18,345 -890 | -5% | -$87K |
|
171
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.7M | 0.03% | 12,875 -1,440 | -10% | -$190K |
|
|
MEMP
172
DELISTED
Memorial Production Partners LP Common Units
MEMP
| $1.62M | 0.03% | 615,000 +20,000 | +3% | +$52.8K |
|
173
AbbVie
ABBV
$372B
| $1.62M | 0.03% | 27,280 -1,300 | -5% | -$77K |
|
174
Mastercard
MA
$538B
| $1.6M | 0.03% | 16,420 -800 | -5% | -$77.9K |
|
175
Walmart
WMT
$774B
| $1.59M | 0.03% | 26,010 -1,250 | -5% | -$76.6K |
|